Sino Medical Sciences Technology Inc. (688108.SS) has a MoatMap StockRank of 28/100 based on Quality (68/100), Value (14/100), and Momentum (34/100) factor scores. The current signal is SELL. Sino Medical Sciences is a medical device company focused on interventional cardiology. While the healthcare sector has defensive qualities, the company lacks alignment with our core macro themes and faces intense domestic volume-based procurement (VBP) pricing pressure in China, destroying its pricing power.
Sino Medical Sciences Technology Inc. develops and manufactures interventional medical devices, specializing in coronary drug-eluting stents and balloon catheters. The company's proprietary BuMA drug-eluting stent technology features unique coating degradation profiles, offering clinical advantages in endothelial healing. It is an innovative cardiovascular medical device company expanding its global footprint through clinical trials in Europe and the US.
| Price | $2.88 |
| Market Cap | $1.4B |
| P/E (TTM) | 121.94 |
| Price/Book | 8.22 |
| Return on Equity | 7.3% |
| Return on Invested Capital | 7.2% |
| Debt/Equity | 13.17 |
| Gross Margin | 67.7% |
| Operating Margin | 23.4% |
| Revenue Growth | 38.6% |
| Free Cash Flow | $2M |
Sino Medical Sciences Technology Inc. operates in the Medical Devices industry, part of the Healthcare sector (China).